530 related articles for article (PubMed ID: 16442398)
1. Search for an optimal atherogenic lipid risk profile: from the Framingham Study.
Nam BH; Kannel WB; D'Agostino RB
Am J Cardiol; 2006 Feb; 97(3):372-5. PubMed ID: 16442398
[TBL] [Abstract][Full Text] [Related]
2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
3. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
Bersot TP; Pépin GM; Mahley RW
Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
[TBL] [Abstract][Full Text] [Related]
4. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
[TBL] [Abstract][Full Text] [Related]
5. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
6. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
[TBL] [Abstract][Full Text] [Related]
7. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2006 Nov; 98(9):1231-3. PubMed ID: 17056335
[TBL] [Abstract][Full Text] [Related]
8. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
Rubins HB; Schectman G; Wilt TJ; Iwane MK
Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850
[TBL] [Abstract][Full Text] [Related]
9. Lifetime risk for developing dyslipidemia: the Framingham Offspring Study.
Cobain MR; Pencina MJ; D'Agostino RB; Vasan RS
Am J Med; 2007 Jul; 120(7):623-30. PubMed ID: 17602937
[TBL] [Abstract][Full Text] [Related]
10. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002).
Panagiotakos DB; Pitsavos C; Skoumas J; Chrysohoou C; Toutouza M; Stefanadis CI; Toutouzas PK
Curr Med Res Opin; 2003; 19(2):89-94. PubMed ID: 12755140
[TBL] [Abstract][Full Text] [Related]
11. Role of lipid and lipoprotein profiles in risk assessment and therapy.
Ballantyne CM; Hoogeveen RC
Am Heart J; 2003 Aug; 146(2):227-33. PubMed ID: 12891189
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein-B, low-density lipoprotein cholesterol, and the long-term risk of coronary heart disease in men.
St-Pierre AC; Cantin B; Dagenais GR; Després JP; Lamarche B
Am J Cardiol; 2006 Apr; 97(7):997-1001. PubMed ID: 16563904
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
14. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
[TBL] [Abstract][Full Text] [Related]
15. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
[TBL] [Abstract][Full Text] [Related]
16. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
17. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
18. Assessing risk factors of coronary heart disease and its risk prediction among Korean adults: the 2001 Korea National Health and Nutrition Examination Survey.
Ko M; Kim MT; Nam JJ
Int J Cardiol; 2006 Jun; 110(2):184-90. PubMed ID: 16412525
[TBL] [Abstract][Full Text] [Related]
19. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
Onat A
Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
[TBL] [Abstract][Full Text] [Related]
20. Improving the prediction of cardiovascular risk: interaction between LDL and HDL cholesterol.
Grover SA; Dorais M; Coupal L
Epidemiology; 2003 May; 14(3):315-20. PubMed ID: 12859032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
